SRF Limited (BOM:503806)
India flag India · Delayed Price · Currency is INR
2,798.45
+17.70 (0.64%)
At close: May 11, 2026

SRF Limited Earnings Call Transcripts

Fiscal Year 2026

  • Q4 25/26

    FY 2026 saw 7% revenue growth and 47% PAT increase, driven by strong chemicals and films performance despite global volatility. Strategic investments, capacity expansions, and robust R&D underpin a 15%-20% growth outlook for FY 2027.

  • Q3 25/26

    Revenue grew 6% year-over-year with EBIT up 23% and net profit up 60%, led by strong chemicals performance and operational efficiencies. Specialty chemicals faced pricing pressure, but a robust pipeline and new investments in pharma and next-gen gases support a positive outlook.

  • Q2 25/26

    Q2 FY26 saw 6% revenue and 56% EBIT growth, led by strong chemicals and refrigerants performance, with robust new product launches and a strategic Chemours partnership. CapEx for FY26 is set at INR 2,200–2,300 crore, and the company expects to surpass 20% full-year chemicals growth.

  • Q1 25/26

    Q1 FY2026 saw robust revenue and profit growth, led by strong performance in chemicals, films, and foils, with new product launches and export gains offsetting domestic demand weakness. CapEx of INR 2,400–2,500 crore is planned, and guidance remains positive for FY2026.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by